UConn researchers validate clinical feasibility for COVID-19 testing at point of care
On Sept. 18, 2020, Uconn researchers, in a paper published in Nature Communications, validated the clinical feasibility of…
On Sept. 18, 2020, Uconn researchers, in a paper published in Nature Communications, validated the clinical feasibility of…
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
On Aug. 28, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) expanded the Emergency Use…
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
On Aug. 15, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to…
On Aug. 4, 2020, Yale University announced it was among the core partners of the new Center for…
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
On Jul. 30, 2020, Precipio announced it had entered into an agreement with ADS Biotec, based in Omaha,…
On Jul. 27, 2020, Yale university researchers reported that differing immune system responses of patients with COVID-19 can…
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
On Jul. 2, 2020, UConn announced a licensing deal with Connecticut Biotech, a startup company headquartered in South…
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
On May 12, 2020, the Jackson Laboratory (JAX), in partnership with the State of Connecticut, announced that it…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop a…
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Oct. 29, 2019, the Yale Science Building officially opened as a central hub for interdisciplinary collaboration on…
On Jul. 18, 2019, the U.S. House of Representatives last week voted to order the Department of Defense…
On Sept. 11, 2018, Joan Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 2018ᅠ…
On Jan. 19, 2018, Yale evolutionary geneticist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal from the…
On Jan. 12, 2018, Connecticut United for Research Excellence Inc. (CURE) renamed itself BioCT and today is the…
In 2018, Rallybio was founded as a privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients…
On Aug. 28, 2017, a team of researchers led by the Yale School of Public Health announced they…
On May 4, 2015, the National Institutes of Health (NIH) dedicated Building 4 in honor of Lowell P….
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…